WHO ICTRP trial
Phase 3 clinical study of AFT-801(confirmatory study 0305) Double-blind…
JPRN-jRCT2080220749 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT2080220749 |
|---|---|
| Public title | Phase 3 clinical study of AFT-801(confirmatory study 0305) Double-blind, placebo-controlled study for excessive daytime sleepiness accompanying obstructive sleep apnea syndrome in CPAP-treated patients |
| Scientific title | Phase 3 clinical study of AFT-801(confirmatory study 0305) Double-blind, placebo-controlled study for excessive daytime sleepiness accompanying obstructive sleep apnea syndrome in CPAP-treated patients |
| Primary sponsor | Mitsubishi Tanabe Pharma Alfresa Pharma Corporation |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | 3 |
| Conditions | Excessive daytime sleepiness accompanying obstructive sleep apnea syndrome in CPAP-treated patients |
| Interventions | investigational material(s) Generic name etc : AFT-801 (Modafinil) INN of investigational material : Therapeutic category code : 117 Psychotropic agents Dosage and Administration for Investigational material : Oral |
| Registration date | Dec 6, 2009 |
| Secondary IDs | JapicCTI-090777 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: